US LEADING DERMATOLOGISTS REVIEW LATISSEĀ® BENEFITS FOR EYELASH GROWTH
Dermatologists provide their expert opinion regarding the benefits and safety of Latisse® for eyelash growth.
(PRWEB) January 4, 2010 -- Patients considering Latisse®, a popular prescription medication that grows longer and darker eyelashes, can now learn the opinion and experience of skin care experts.
Dermatologists have published their expert opinion regarding Latisse®, providing patients with a reliable source of health information.
Christine Brown, M.D., a Dallas dermatologist in private practice, provided her expert opinion about Latisse® and suggested that the incidence of side effects, such as pigmentation of the eye or surrounding skin is exceptionally rare. The most common side effect is redness, which is a transient problem. " Latisse® works well, especially under the supervision of a dermatologist."
Amy McMichael, M.D., pointed out that "the data for the safety of Latisse® is well studied since this medication has been around in eyedrop form for more than 8 years. The post-marketing studies of Lumigan [an eye medication with the same active ingredient as Latisse and the more recent FDA pivotal studies for Latisse underscore the safety of the drug. Anecdotally, many patients who used Lumigan for glaucoma in one eye only have applied Lumigan to the other eye to even out the lash growth--under the supervision of their ophthalmologist and without unwanted side effects."
The clinical judgment provided by dermatologists are published by Vivacare, a patient education company that provides dermatologists with tools to educate their patients and the public about skin conditions and offer skin care advice.
About Vivacare
Vivacare is a patient education company based in Berkeley, California that supports the physician-patient relationship by helping medical professionals share practical health information with their patients, leading to improved clinical care and patient satisfaction. Over 2,000 dermatologists use Vivacare's "fromyourdoctor" service to deliver health information regarding acne and other skin conditions to their patients.
Read the full story at http://www.prweb.com/releases/2010/01/prweb3403504.htm.
Original Article: http://www.prweb.com/releases/2010/01/prweb3403504.htm
